Home | Recruitment

Pending

Trials by recruitment status

Public Title Date of registration Sponsor
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 08/10/2015 CIM
VSSP in metastasic renal cell carcinoma 08/08/2018 CIM
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer 08/07/2015 CIM
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans 07/08/2023 HHA
AMIGOS-2 study 07/08/2018 CIGB
CERVICONC-II-300 study 07/08/2018 CIGB
Prevenox Plus versus original Prevenox: Comparison of effects in healthy volunteers 07/03/2025 CPN
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. 07/03/2024 CATALYSIS
14F7 in chronic B-cell lymphoproliferative syndrome 07/03/2018 CIM
Nasal recombinant human interferon alfa-2b in ARI 06/12/2022 CIGB
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . 06/11/2014 FINLAY
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19. 06/09/2024 CIGB
Transfer factor in Chronic Kidney Disease 06/08/2020 CIGB
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock 06/07/2023 CIGB
Nimotuzumab cold kit for the immunodiagnosis of solid tumors 05/10/2018 CIM
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma 05/09/2017 CIM
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib 05/08/2021 ROCHE
Lithium Carbonate-COVID-19- mild and moderate -Exploratory / Phase II 05/08/2021 ICBPGirón
Rectal Ozone in the COVID-19 treatment 05/06/2020 CPN
Oncoxin®-Viusid®- Quality of life of patients with metastatic colorectal adenocarcinoma-adults-Phase II 05/06/2018 CATALYSIS